Collector
The drug, daraxonrasib, targets the gene mutation behind most pancreatic cancer diagnoses. | Collector
The drug, daraxonrasib, targets the gene mutation behind most pancreatic cancer diagnoses.
USA TODAY

The drug, daraxonrasib, targets the gene mutation behind most pancreatic cancer diagnoses.

The drug, daraxonrasib, targets the gene mutation behind most pancreatic cancer diagnoses.

Go to News Site